Active Wellness Management
The goal of the Active Disease Risk Management (ADRM) digital therapeutics (DTx) solutions is to improve patient engagement, prevent disease complications and expand access to timely, effective treatment. Our solution is delivered via connected medical devices that deliver frequent and reliable home biodata readings onto a digital health platform, which is accessed by the professional care team. The team then tracks patient progress and make changes to treatment plans in collaboration with the treating clinician.
Patient Engagement
CareDTx™ patient engagement process is an active involvement of our registered individuals in their own healthcare, from everyday decisions about managing a condition to collaborating with providers on treatment plans. We provide education and information, making sure patients understand their diagnosis and test results outcomes. The process allows patients to ask questions, weigh options with their clinicians, track their own health data, and participate in every decision that affect their care.
Our engagement goal is to create a genuine partnership where the patient and care provider discuss treatment options together, weigh the trade-offs, and arrive at a plan that reflects the patient's values and preferences.
Digital Therapeutics
Using innovative health technology, subscribing patients are provided with digital self-measuring devices to use outside clinical settings. The devices have Bluetooth technology which ensures digital recording of self-measured data via mobile Apps onto a digital cloud based platform. This self-measured biodata is accessed and monitored by a team of healthcare professionals who provide collaborative (with the treating doctor) and personalized care.
Our digital therapeutics (DTx) solutions increase the accessibility of chronic disease management services, where continuous support and long-term engagement are essential.
Ensuring Treatment Efficacy
There are standard treatment protocols for chronic disease management, however patients living with a chronic disease will respond differently to prescribed medication. The primary goal for phamacotherapy is to control, manage and prevent potential disease complications. The goal of our solution is to ensure disease control.
A significant number of patients on chronic disease medication are not controlled. This is observed in patients suffering complications while on chronic treatment. As part of our solutions, remote monitoring of self-measured biodata (weight, blood pressure, glucose, total cholesterol etc.) alets our professional team to poor drug efficacy and sometimes patient non-adherence.